非酒精性脂肪性肝病：一种多系统疾病*

doi:10.3969/j.issn.1672-5069.2017.03.001

实用肝脏病杂志 ›› 2017, Vol. 20 ›› Issue (3): 257-259.doi: 10.3969/j.issn.1672-5069.2017.03.001

• 述评 • 下一篇

非酒精性脂肪性肝病：一种多系统疾病^*

金沛桦, 施军平

杭州师范大学医学院肝病科

收稿日期:2017-03-20 出版日期:2017-06-10 发布日期:2018-03-10
通讯作者: 施军平,E-mail：13957121199@vip.126.com
作者简介:金沛桦,男,25岁,浙江中医药大学2015级硕士研究生。主要研究方向为脂肪肝的基础与临床研究。E-mail：594637923@qq.com
基金资助:
*杭州市卫生计生科技计划重大项目（编号：2015ZD02）; 王宝恩肝纤维化研究基金资助项目（编号：20131041）

Nonalcoholic fatty liver disease: A multisystem disease

Jin Peihua, Shi Junping

Department of Hepatology, Affiliated Hospital,College of Medicine,Hangzhou Normal University,Hangzhou 310015,Zhejiang Province,China

Received:2017-03-20 Online:2017-06-10 Published:2018-03-10
Contact: Corresponding author:Shi Junping, E-mail:13957121199@vip.126.com

摘要/Abstract

关键词: 非酒精性脂肪性肝病, 糖尿病, 动脉硬化, 慢性肾病, 高尿酸血症

Key words: Nonalcoholic fatty liver disease, Diabetes, Arteriosclerosis, Hyperuricemia

金沛桦, 施军平. 非酒精性脂肪性肝病：一种多系统疾病^*[J]. 实用肝脏病杂志, 2017, 20(3): 257-259.

Jin Peihua, Shi Junping. Nonalcoholic fatty liver disease: A multisystem disease[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 257-259.

[1] Armstrong MJ,Adams LA,Canbay A,et al.Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology,2014,59:1174-1197.
[2] Fan JG,Li F,Cai XB,et al.Effects of nonalcoholic fatty liver disease on the development of metabolic disorders.J Gastroenterol Hepatol,2007,22:1086-1091.
[3] Vernon G,Baranova A,Younossi ZM.Systematic review:the epidemiolory and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther,2011,34:274-285.
[4] Sung KC,Jeong WS,Wild SH,et al.Combined influence of insulin resistance,overweight/obesity,and fatty liver as risk factors for type 2 diabetes. Diabetes Care,2012,35:717-722.
[5] Masuoka HC,Chalasani N.Nonalcoholic fatty liver disease:an emerging threat to obese and diabetic individuals. Ann N Y Acad Sci,2013,1281:106-122.
[6] Balkau B,Lange C,Vol S,et al.Nine-year incident diabetes is predicted by fatty liver indices:the French D.E.S.I.R. study. BMC Gastroenterol,2010,10:56.
[7] Shibata M,Kihara Y,Taguchi M,et al.Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care,2007,30:2940-2944.
[8] Zoppini G,Fedeli U,Gennaro N,et al.Mortality from chronic liver diseases in diabetes. Am J Gastroenterol,2014,109:1020-1025.
[9] Anstee QM,Targher G,Day CP.Progression of NAFLD to diabetes mellitus,cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol,2013,10:330-344.
[10] Sinn DH,Kang D,Chang Y,et al.Non-alcoholic fatty liver disease and progression of coronary artery calcium score:a retrospective cohort study. Gut,2016,66(2):311854.
[11] Wong VW,Wong GL,Yip GW,et al.Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut,2011,60:1721-1727.
[12] Targher G,Day CP,Bonora E.Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med,2010,363:1341-1350.
[13] Lu H,Liu H,Hu F,et al.Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease:A systematic review and Meta-analysis. Int J Endocrinol,2013,2013(2013):124958.
[14] Targher G,Chonchol MB,Byrne CD.CKD and nonalcoholic fatty liver disease. Am J Kidney Dis,2014,64:638-652.
[15] Musso G,Gambino R,Cassader M,et al.Meta-analysis:natural history of non-alcoholic fatty liver disease(NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med,2011,43(8):617-649.
[16] Arase Y,Suzuki F,Kobayashi M,et al.The development of chronic kidney disease in Japanese patients with nonalcoholic fatty liver disease. Intern Med,2011,50:1081-1087.
[17] Yasui K,Sumida Y,Mori Y,et al.Nonalcoholic steatohepatitis and increased risk of chronic kidney disease. Metabolism,2011,60:735-739.
[18] Xu C,Wan X,Xu L,et al.Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia:One stone hits two birds. J Hepatol,2015,62(6):1412-1419.
[19] Li Y,Xu C,Yu C,et al.Association of serum uric acid level with non-alcoholic fatty liver disease:a cross-sectional study. J Hepatol,2009,50(5):1029-1034.
[20] Bonora E,Targher G.Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. Nat Rev Gastroenterol Hepatol,2012,9:372-381.
[21] Targher G,Chonchol M,Zoppini G,et al.Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link [J] Hepatol,2011,54:1020-1029.
[22] Hamaguchi M,Kojima T,Takeda N,et al.Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol,2007,13:1579-1584.

非酒精性脂肪性肝病：一种多系统疾病^*

Nonalcoholic fatty liver disease: A multisystem disease

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	任俞霏, 陈小青, 孔维宗, 王迎春. 丹酚酸B对非酒精性脂肪性肝病细胞模型自噬功能的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 804-807.
[2]	李颖怡, 郭翠芬, 章瑞南, 汪保灿, 潘勤, 汪余勤, 曹海霞, 范建高. ALDH2 rs671基因多态性与非酒精性脂肪性肝病相关性研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 848-851.
[3]	邢欣, 魏重操, 周咪咪, 李小玲, 邓江, 鲁晓岚. 牛磺熊去氧胆酸与熊去氧胆酸治疗非酒精性脂肪性肝病患者疗效和安全性的Meta分析[J]. 实用肝脏病杂志, 2019, 22(6): 852-855.
[4]	武丹, 马向鹰. 非酒精性脂肪性肝病肝硬化患者胰岛素抵抗水平与颈动脉硬化程度和左心室功能研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 876-879.
[5]	张胥磊, 杨庆余, 韩秋玉, 缪鋆鋆, 蔡仁诚, 马亦旻. 自拟中药治疗非酒精性脂肪性肝病患者血清炎症反应指标水平的变化*[J]. 实用肝脏病杂志, 2019, 22(5): 660-663.
[6]	张梅, 石秀英, 李林娟, 薛亚妮. 肝源性糖尿病患者肝组织干扰素诱导蛋白-10表达变化*[J]. 实用肝脏病杂志, 2019, 22(5): 688-691.
[7]	张兰华, 邵琴, 夏振娟. 非酒精性脂肪性肝病儿童血清25-（OH）D3和IL-17水平变化初步研究^*[J]. 实用肝脏病杂志, 2019, 22(4): 522-525.
[8]	谢晓, 刘婷, 董志霞, 夏幼辰, 张启迪, 曲颖, 蔡晓波, 徐铭益, 陆伦根. FibroTouch检测肝脏受控衰减参数对肝脂肪变的诊断价值分析^*[J]. 实用肝脏病杂志, 2019, 22(4): 526-529.
[9]	符亮, 吴冬冰, 纪新尊, 万鸿兴, 李文刚, 饶卉明, 钟静, 江婷婷. 超声定量评估非酒精性脂肪性肝病患者肝脏ARFI值对显著NASH的诊断价值分析[J]. 实用肝脏病杂志, 2019, 22(3): 377-380.
[10]	张婷婷（综述）, 王煊（审校）. 肝硬化患者口服葡萄糖耐量试验临床意义及研究进展[J]. 实用肝脏病杂志, 2019, 22(3): 449-452.
[11]	朱光曦（综述）, 文良志, 陈东风（审校）. 非酒精性脂肪性肝病相关肝细胞癌发病机制研究进展[J]. 实用肝脏病杂志, 2019, 22(3): 453-456.
[12]	霍会芹,巩晓红,李正宏. 采用实时三维超声和斑点追踪技术评价非酒精性脂肪性肝病肝硬化患者右心功能^*[J]. 实用肝脏病杂志, 2019, 22(2): 244-247.
[13]	苏淑婷,钟燕（综述）,宓余强（审校）. 非酒精性脂肪性肝病分级分期管理研究进展[J]. 实用肝脏病杂志, 2019, 22(2): 293-296.
[14]	谢晓（综述）,陆伦根（审校）. 无创诊断和评估非酒精性脂肪性肝炎研究进展^*[J]. 实用肝脏病杂志, 2019, 22(2): 301-306.
[15]	张枫, 阎妍. 非酒精性脂肪性肝病患者血清载脂蛋白B水平及其临床意义探讨^*[J]. 实用肝脏病杂志, 2019, 22(1): 61-64.